This article has been corrected: For purposes of clarity, Figure 2B has been updated. In the corrected Figure 2B , a clear vertical line was added to each band, as well as two new labels ("exogenous synthetic" and "cell component") in the bottom of the figure in order to more clearly point out that the left side of the line represents exogenous synthetic AMF, while the right side is cell component. In addition, the figure legend of Figure 2B has been corrected to read: "B. Top, Immunoblot analysis for AMF protein and β-actin expression. The band on the left side of the vertical line were exogenous synthetic, and the band on the right side were cell component. Bottom, quantification analysis of AMF expression. AMF cytokine itself was used as positive control."
identified protein factors whose phosphorylation states changed in HEC-1B cells when AMF was stably knocked down by shRNA (Top). The signal intensities of phosphorylated proteins and total protein levels were determined. The log-fold changed of each protein was determined as the ratio between the percentages of phosphorylated proteins in total proteins in HEC-1B/mock and HEC-1B/shAMF-1 (Bottom). In the top panel, the red squares show the downregulation of the phosphorylated proteins, and blue squares show upregulation of the phosphorylated proteins between HEC-1B/mock and HEC-1B/shAMF-1 cells. (B and C) Ishikawa and HEC-1B cells were serumstarved for 16 hours were stimulated with purified PGI; p-ERK levels were monitored by western blot for dose-dependent effects of PGI (0-20 ng/mL) after 15 minutes (B) and for time-dependent dffects (0-30 min) with 10 ng/mL PGI (C). (D) The effect of U0126 (20 μmol/L; MAPK inhibitor) on PGI-induced ERK1/2 phosphorylation assessed by western blotting. Serum-starved cells were pretreated with U0126 for 1 hour before PGI (10 ng/mL) stimulation for 15 minutes. (E) The effect of AMF knockdown on ERK1/2, MEK1/2, and MAPKAPK2 phosphorylation was evaluated by western blotting; β-actin was used as a loading controls.
